Opal, S.M. (2003) Clinical trial design and outcomes in patients with severe sepsis. Shock 20, 295-302.

Polderman, K.H., and Girbes, A.R. (2004) Drug intervention trials in sepsis: divergent results. Lancet 363, 1721-3.

Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., and Medzhitov R. (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229-41.

Reumaux, D., Duthilleul, P., and Roos, D. (2004) Pathogenesis of diseases associated with antineutrophil cytoplasm autoantibodies. Hum. Immunol. 65, 1-12.

Rice, L., Orlow, D., Ceonzo, K., Stahl, G.L., Tzianabos, A.O., Wada, H., Aird, W.C., and Buras, J.A. (2005) CpG oligodeoxynucleotide protection in polymicrobial sepsis is dependent on interleukin-17. J. Infect. Dis. 191, 1368-76.

Rossignol, D.P., and Lynn, M. (2005) TLR4 antagonists for endotoxemia and beyond. Curr. Opin. Investig. Drugs 6(5), 496-502.

Smith, K.D., and Bolouri, H. (2005) Dissecting innate immune responses with the tools of systems biology. Curr. Opin. Immunol. 17, 49-54.

Tracey, K.J., Czura, C.J., and Ivanova, S. (2001) Mind over immunity. FASEB J. 15, 1575-6.

Tzianabos, A.O., and Kasper, D.L. (2002) Role of T cells in abscess formation. Curr. Opin. Microbiol. 5, 92-6.

Wiendl, H., and Hohlfeld, R. (2002) Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials. BioDrugs 16, 183-200.

Wilson M. (2005) Microbial Inhabitants of Humans. Cambridge, UK: Cambridge University Press.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement